|Bid||560.00 x 151300|
|Ask||0.00 x 209800|
|Day's range||594.00 - 619.00|
|52-week range||239.40 - 654.00|
|PE ratio (TTM)||N/A|
|Earnings date||26 May 2017 - 29 May 2017|
|Forward dividend & yield||0.05 (0.66%)|
|1y target est||8.60|
** Network security solutions provider Sophos up 5.1 pct, hits all-time high ** Co says billings at reported exchange rates increased by 22 pct to $341.5 mln ** Raising outlook for billings and unlevered ...
MADRID/LONDON (Reuters) - The owners of Avast Software have hired Rothschild to prepare the business for a share sale which could value one of the world's most used providers of computer antivirus software at as much as $4 billion (£3 billion), four sources familiar with the matter told Reuters. CVC Capital Partners [CVC.UL], which took control of the Prague-based company in 2014, could seek an initial public offering (IPO) in London for Avast in the first half of next year if market conditions allow, two of the sources said. CVC and Rothschild declined to comment.
Cloud services and network security company Sophos raised its full-year forecast for the amount it bills its customers to growth of 20 percent, from a previous target of mid to high-teens, citing "strong ...
For Kris Hagerman, chief executive of UK-based cyber security firm Sophos Group Plc (Frankfurt: 2SO.F - news) , the past week could have been bad. The WannaCry "ransomware" attack hobbled some of its hospital customers in Britain's National Health Service, forcing them to turn away ambulances and cancel surgeries. The company quickly removed a boast on its website that “The NHS is totally protected with Sophos.” In many industries, that sort of stumble would likely hit a company's reputation hard.
Live coverage of European markets now available on cpurl://apps.cp./cms/?pageId=livemarkets Summary: **STOXX 600 down 0.2 pct **Anti-virus provider Sophos jumps 7 pct after global ransomware attack **Atlantia ...
British IT security company Sophos has agreed to buy malware protection company Invincea for $100 million to bolster its product line and give it a stronger presence in the U.S. government, healthcare ...